<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Epidemiology and toxicity of cadmium
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Epidemiology and toxicity of cadmium
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Epidemiology and toxicity of cadmium
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carl-Gustaf Elinder, MD, PhD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kavita M Babu, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Gary C Curhan, MD, ScD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Eric N Taylor, MD, MSc, FASN
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 08, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cadmium (Cd) is a metal that can cause severe acute or chronic toxicity in humans. Most cases of cadmium toxicity are due to chronic exposure. Chronic, low-level cadmium exposure can affect a variety of organs, with the kidneys and bones being the principal targets [
         <a href="#rid1">
          1-3
         </a>
         ]. Acute cadmium toxicity is less common. Depending upon the route of exposure, acute cadmium toxicity primarily affects the lungs and gastrointestinal tract.
        </p>
        <p>
         This topic reviews chronic and acute cadmium toxicity. Other heavy metal toxicities are discussed elsewhere:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7179.html" rel="external">
          "Mercury toxicity"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7180.html" rel="external">
          "Lead nephropathy and lead-related nephrotoxicity"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6491.html" rel="external">
          "Childhood lead poisoning: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2778.html" rel="external">
          "Arsenic exposure and chronic poisoning"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9035802">
         <span class="h1">
          CHRONIC HUMAN EXPOSURE
         </span>
        </p>
        <p class="headingAnchor" id="H9035932">
         <span class="h2">
          Source of exposure
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cadmium is a relatively rare heavy metal that occurs naturally in combination with zinc. Environmental contamination and consequent human exposure to cadmium have dramatically increased during the past 100 years [
         <a href="#rid4">
          4,5
         </a>
         ]. Used in electroplating and battery manufacturing, cadmium commonly contaminates the environment via household waste, industrial emissions, and soil. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cadmium-containing products are frequently thrown out with the household garbage; the metal is then released into the atmosphere if the waste is burned.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cadmium emissions are released from mining and nonferrous smelters.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Soil may become contaminated via atmospheric emissions and sewage sludge. Land used for farming can also contain cadmium due to the use of phosphate fertilizers containing the metal. Cadmium is readily absorbed by plants grown in cadmium-containing soil, particularly grain, rice, and vegetables.
        </p>
        <p>
        </p>
        <p>
         Exposure to cadmium principally results from eating contaminated food, smoking cigarettes, and working in cadmium-contaminated workplaces.
        </p>
        <p class="headingAnchor" id="H9036082">
         <span class="h3">
          Food intake
         </span>
         <span class="headingEndMark">
          —
         </span>
         The daily intake of cadmium through food varies in part by geographic region. As an example, intake is reported to be approximately 8 to 30 mcg in Europe and the United States versus 59 to 113 mcg in various areas of Japan [
         <a href="#rid6">
          6
         </a>
         ]. There is also a wide individual variation in cadmium intake based upon the type and amount of food consumed. Since this variation follows a log-normal distribution, most individuals ingest between 4 and 60 mcg per day (eg, ±2 standard deviations [SDs]) if the average individual intake is 15 mcg per day [
         <a href="#rid7">
          7,8
         </a>
         ].
        </p>
        <p>
         The average gastrointestinal absorption is 5 percent. Thus, the net absorbed amount of cadmium is approximately 1 to 2 mcg per day in Europe and the United States and up to 5 mcg in areas in Japan. In certain areas of Japan, such as the Jinzu river basin and Kakehashi river basin, which are considered highly contaminated with cadmium, the net ingestion is higher [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
         The gastrointestinal absorption of dietary cadmium is increased by mild iron deficiency [
         <a href="#rid10">
          10
         </a>
         ]. As a result, chronically iron-deficient individuals are at higher risk for environmental cadmium exposure. (See
         <a class="local">
          'Risk factors'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H9036096">
         <span class="h3">
          Smoking
         </span>
         <span class="headingEndMark">
          —
         </span>
         Smoking is a potentially important route of cadmium exposure. Individuals who smoke 20 cigarettes a day absorb nearly 1 mcg of cadmium via the lungs, an amount similar to the quantity absorbed via food in Europe and the United States [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9036102">
         <span class="h3">
          Occupational exposure
         </span>
         <span class="headingEndMark">
          —
         </span>
         The workplace constitutes the most important source of cadmium exposure among individuals engaged in cadmium production and the industrial use of cadmium. Major industrial applications for cadmium are in the production of alloys, galvanizing pigments, and nickel-cadmium batteries. Over one million individuals worldwide are believed to be occupationally exposed to cadmium.
        </p>
        <p>
         The permissible occupational threshold limit values range from 0.005 to 0.05 mg Cd/m
         <sup>
          3
         </sup>
         in air in various countries. The Occupational Safety and Health Administration (OSHA) of the United States has set the permissible exposure limit for cadmium in air to 0.005 mg Cd/m
         <sup>
          3
         </sup>
         [
         <a href="#rid1">
          1,11
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9036155">
         <span class="h2">
          Metabolism after exposure
         </span>
         <span class="headingEndMark">
          —
         </span>
         Gastrointestinal absorption following oral intake is relatively poor, with the highest estimates for bioavailability listed at approximately 10 percent [
         <a href="#rid12">
          12
         </a>
         ]. Inhalational absorption is far more efficient, with a bioavailability of up to 50 percent. However, total absorbed cadmium dose is also dependent on inhaled particle size. Small particles (&lt;0.1 micrometer) are more likely to penetrate to the alveoli, where cadmium absorption occurs [
         <a href="#rid13">
          13
         </a>
         ]. After ingestion of contaminated food or inhalation via cigarette smoking or at the workplace, cadmium is transported to the liver, where metallothionein, a cadmium- and zinc-binding protein, is synthesized [
         <a href="#rid8">
          8
         </a>
         ]. Metallothionein serves as a detoxifying protein by binding cadmium and preventing free cadmium ions from disturbing normal cellular functions. It is also responsible for the pronounced accumulation of cadmium in the liver and kidneys.
        </p>
        <p>
         Metallothionein, which has a molecular weight of approximately 7000 daltons, migrates slowly from the liver cells into the blood stream, where it is transported to the kidneys. As with other small proteins, it is freely filtered across the glomerulus and then reabsorbed by the proximal tubular cells via pinocytosis. In the tubular cells, metallothionein enters the lysosomes, where it is degraded by lysozymes, releasing free cadmium ions into the tubular cell cytoplasm.
        </p>
        <p>
         The renal tubular cells have a considerable capacity to synthesize metallothionein, which binds the toxic cadmium ions. At some point, however, the kidneys' detoxifying capacity is surpassed, and free cadmium causes tubular damage, interstitial inflammation, and eventually fibrosis and glomerular injury [
         <a href="#rid1">
          1,11
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9033914">
         <span class="h2">
          Disease associations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Chronic cadmium exposure causes toxicity of the kidney and bones. Chronic exposure may also be associated with lung cancer and may cause emphysema.
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h3">
          Kidney disease
         </span>
        </p>
        <p class="headingAnchor" id="H1587810055">
         <span class="h4">
          Manifestations
         </span>
         <span class="headingEndMark">
          —
         </span>
         The majority of patients with cadmium-associated kidney disease have isolated tubular defects that are only detected by specific testing [
         <a href="#rid14">
          14,15
         </a>
         ]. Early manifestations include an increased excretion of low-molecular-weight proteins, such as beta2-microglobulin [
         <a href="#rid11">
          11
         </a>
         ]. In almost all cases, tubular proteinuria is irreversible, even if exposure has ceased [
         <a href="#rid16">
          16-18
         </a>
         ].
        </p>
        <p>
         Some workers exposed to cadmium have a slightly increased urinary excretion of albumin, which may be related to a glomerular lesion or represent decreased tubular reabsorption of the small amount of albumin that is normally filtered through the glomerulus [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p>
         In more severe cases of cadmium toxicity, patients present with evidence of kidney interstitial injury, including the following [
         <a href="#rid1">
          1,11,20,21
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Renal glucosuria
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Aminoaciduria
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Renal phosphate wasting
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hypercalciuria
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Polyuria due to decreased concentration capacity
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diminished ability to handle an acid (NH
         <sub>
          4
         </sub>
         Cl) load
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decreased glomerular filtration rate (GFR)
        </p>
        <p>
        </p>
        <p>
         Despite tubular damage, kidney disease does not appear to progress in most individuals if exposure ceases. In a five-year follow-up study of nearly 600 Belgian individuals with initially mild evidence of tubular damage and decreasing exposure to cadmium, there was no evidence of progressive kidney damage [
         <a href="#rid22">
          22
         </a>
         ]. Thus, patients with isolated tubular defects rarely have symptoms or clinically evident disease. However, there are several exceptions to this:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Some individuals develop kidney stones as a result of hypercalciuria, which is a known risk factor for stone development (see
         <a class="medical medical_review" href="/z/d/html/7375.html" rel="external">
          "Kidney stones in adults: Epidemiology and risk factors", section on 'High urine calcium'
         </a>
         ). The prevalence of symptomatic kidney stones is increased among individuals occupationally exposed to cadmium [
         <a href="#rid1">
          1,11,23
         </a>
         ]. In one report, for example, a dose-response relationship was demonstrated between cumulative cadmium exposure among a group of battery workers and the age-adjusted cumulative incidence of kidney calculi  (
         <a class="graphic graphic_figure graphicRef74139" href="/z/d/graphic/74139.html" rel="external">
          figure 1
         </a>
         ). Hypercalciuria is thought to be a primary determinant of stone formation in such patients [
         <a href="#rid24">
          24,25
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Some individuals, presumably those with more severe exposure to cadmium, present with a decreased estimated GFR (eGFR) [
         <a href="#rid11">
          11,26-28
         </a>
         ]. There is an association among the degree of tubular dysfunction, the cadmium dose, and a decrease in GFR  (
         <a class="graphic graphic_figure graphicRef74549" href="/z/d/graphic/74549.html" rel="external">
          figure 2
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Some individuals who have significant environmental cadmium exposure progress to end-stage kidney disease (ESKD). As an example, uremia was a common cause of death among Japanese farmers suffering from cadmium-induced osteomalacia (see
         <a class="local">
          'Bone disease'
         </a>
         below) and has been observed in workers previously heavily exposed to cadmium [
         <a href="#rid1">
          1
         </a>
         ]. Additionally, in a large cohort study from a cadmium-polluted area of Sweden, the age-standardized incidence rate ratio (SRR) of requiring kidney replacement therapy over an 18-year period was higher among those with increased exposure to cadmium [
         <a href="#rid27">
          27
         </a>
         ]. The SRR among those with low, moderate, and high cadmium exposure was 1.4, 1.9, and 2.3, respectively.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3690003614">
         <span class="h4">
          Pathology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Few reports of kidney biopsies from cadmium-poisoned individuals have been published. Tubular atrophy, ischemic and degenerative glomerular lesions, interstitial fibrosis, and marked subcapsular lymphocytic infiltration were found in the kidneys of a man who died from cadmium-induced uremia [
         <a href="#rid29">
          29
         </a>
         ]. In a study of kidney biopsies from 109 healthy kidney donors, tissue concentrations of cadmium were associated with mild tubular atrophy [
         <a href="#rid30">
          30
         </a>
         ]; these histopathologic changes were consistent with those previously found in the kidneys of horses who had a higher degree of cadmium exposure [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9034591">
         <span class="h4">
          Risk factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         In addition to cadmium exposure, risk factors for cadmium-induced nephrotoxicity include age, diabetes mellitus, and iron deficiency.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cadmium exposure
         </strong>
         – Multiple epidemiologic studies have associated endemic outbreaks of cadmium-induced kidney disease in Japan with consumption of cadmium-contaminated rice [
         <a href="#rid1">
          1,9,11
         </a>
         ]. Other studies from certain areas of Belgium, China, Japan, and Sweden demonstrated an association between high body cadmium burdens and kidney dysfunction [
         <a href="#rid9">
          9,32-34
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Chronic exposure of the kidney to cadmium is reflected in the urinary cadmium excretion. The threshold urinary cadmium excretion that is associated with toxicity is not known but is probably lower than was initially suggested (5 to 10 mcg per gram of creatinine) [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Subsequent reports, however, indicate that toxicity may occur at much lower urinary cadmium concentrations [
         <a href="#rid5">
          5,7,34
         </a>
         ]. A number of studies have suggested that increased secretion of tubular proteins may occur at urine cadmium concentrations exceeding a level of only 1 to 5 mcg Cd/g creatinine (or 2 to 3 nmol Cd/mmol creatinine) [
         <a href="#rid32">
          32,34,36,37
         </a>
         ]. In one study, depending upon age, the prevalence of beta2-microglobulinuria was 5 to 15 percent at urinary cadmium concentrations of 3 nmol/mmol creatinine  (
         <a class="graphic graphic_figure graphicRef74549" href="/z/d/graphic/74549.html" rel="external">
          figure 2
         </a>
         ). Among 820 environmentally exposed postmenopausal females (aged 53 to 64 years), cadmium levels in blood and urine were associated with reduced eGFR and increased markers of tubular injury; these associations were seen at a mean urinary cadmium level as low as 0.8 nmol/mmol creatinine [
         <a href="#rid38">
          38
         </a>
         ]. However, associations between eGFR and cadmium were only recorded when smokers were included in the multiple regression analysis, which suggests that confounding from smoking may be a problem in the interpretation of the findings.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Even lower urinary cadmium concentrations have been associated with proteinuria in some studies [
         <a href="#rid39">
          39
         </a>
         ]. However, these associations appear to be largely driven by current smoking, variations in diuresis, and probably also the co-excretion in urine of Cd with proteins [
         <a href="#rid40">
          40
         </a>
         ]. The assessment of data of a large cohort of nickel-cadmium battery workers revealed that the kidney effects of chronic smoking substantially distort the dose effect/response relationships [
         <a href="#rid41">
          41
         </a>
         ]. On the basis of associations undistorted by smoking and adjusted for covariates, the threshold for low-molecular-weight proteinuria induced by occupational exposure to Cd was estimated between 5.5 and 6.6 nmol/mmol creatinine [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A review of the literature combined with an analysis of the risks from environmental cadmium exposure concluded that there is a low margin of safety between current levels of exposure to cadmium and that which may cause kidney toxicity [
         <a href="#rid7">
          7
         </a>
         ]. If the average daily intake of cadmium is increased from 15 to 30 mcg, approximately 1 percent of the adult population would be expected to develop renal tubular damage (as detected by tubular proteinuria). In certain high-risk groups, such as females with poor iron stores, the percentage affected would be even higher.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Age
         </strong>
         – Older individuals are more likely to develop kidney toxicity at a given level of cadmium exposure [
         <a href="#rid34">
          34
         </a>
         ]. In an examination of Swedish battery workers, a 10 percent prevalence of tubular proteinuria associated with a cadmium level of 1.5 nmol/mmol creatinine was found in the older age group versus 5 nmol/mmol creatinine in the younger subjects  (
         <a class="graphic graphic_figure graphicRef74549" href="/z/d/graphic/74549.html" rel="external">
          figure 2
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Several reasons have been advanced as to why older individuals have a higher prevalence of kidney dysfunction when exposed to cadmium. Older individuals may have an increased cadmium body burden with age due to higher amounts of cadmium accumulated in the kidney from both occupational exposure and environmental sources (food, tobacco). Degenerative changes in the renal tubules with age may predispose to cadmium-induced tubular injury and accelerate the rate of cadmium-induced kidney dysfunction.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diabetes –
         </strong>
         Observational data suggest that individuals with diabetes mellitus also have a higher risk of developing kidney dysfunction from cadmium exposure [
         <a href="#rid16">
          16,42
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Iron deficiency
         </strong>
         – Individuals with iron deficiency may be at higher risk for cadmium toxicity. This is because iron deficiency results in higher gastrointestinal cadmium absorption.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h3">
          Bone disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cadmium toxicity is associated with bone disease. Bone disease due to prolonged exposure to cadmium was first reported among exposed individuals living in the Jinzu river basin in Japan, an area that is highly contaminated with cadmium. Exposure to cadmium was caused by contaminated river water used for irrigation of rice fields. Cadmium toxicity resulted in Itai-Itai ("Ouch-Ouch") disease, an illness characterized by multiple fractures, a mixed pattern of osteoporosis and osteomalacia, and kidney damage [
         <a href="#rid1">
          1,11,43,44
         </a>
         ]. The diagnosis of osteomalacia was made by clinical manifestations including multiple fractures, vertebral compressions, shortening of stature, and other radiograph and autopsy findings. Bone biopsies were generally not performed. A few additional reports have described similar bone disorders in workers with kidney damage and a history of heavy exposure to cadmium [
         <a href="#rid1">
          1,11,45
         </a>
         ].
        </p>
        <p>
         A dose-dependent association of cadmium exposure with osteoporosis and bone fractures is described in numerous observational studies [
         <a href="#rid2">
          2,3,46-55
         </a>
         ]. These studies, which included individuals who had lower-intensity cadmium exposure than those in the original case series, ascertained cadmium exposure using blood and/or urine levels or an estimation of dietary intake.
        </p>
        <p>
         The following examples illustrate the range of findings:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A prospective cohort of 506 individuals living in proximity to zinc smelters in Belgium underwent baseline measurement of urinary cadmium excretion with assessments of forearm bone mineral density and fracture incidence a mean of 6.6 years later [
         <a href="#rid47">
          47
         </a>
         ]. Urinary cadmium excretion was inversely correlated with future bone mineral density. In addition, a twofold higher urinary cadmium excretion was associated with a 73 percent increased risk of fracture in females after controlling for other variables and a 60 percent increased risk of height loss in males.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A cross-sectional study of 1021 individuals who resided near or worked in two battery plants in Sweden had measurements of blood cadmium and forearm bone mineral density [
         <a href="#rid49">
          49
         </a>
         ]. Among those aged ≥60 years, blood cadmium was independently and inversely correlated with bone mineral density in females. In both males and females ≥60 years, a blood cadmium of ≥10 nmol/L was associated with a threefold higher prevalence of osteoporosis (defined as a z-score &lt;-1) compared with those who had a blood cadmium &lt;5 nmol/L.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Another cross-sectional study of 2688 females examined the association of the urine cadmium-to-creatinine ratio with bone mineral density and the prevalence of fractures [
         <a href="#rid52">
          52
         </a>
         ]. After controlling for potential confounders, a higher urine cadmium-to-creatinine ratio was significantly and inversely correlated with bone mineral density and positively associated with the prevalence of osteoporosis. This relationship was stronger in females who had never smoked compared with females who smoked. In addition, the prevalence of fractures was twofold higher in nonsmoking females whose cadmium-to-creatinine ratio was &gt;0.75 mcg/g compared with nonsmoking females whose ratio was &lt;0.5 mcg/g. A 1 nmol Cd/mmol creatinine equals 1 mcg Cd/g creatinine.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The association of estimated dietary cadmium intake and incidence of fractures was analyzed in a prospective, population-based cohort of Swedish males followed for 10 years [
         <a href="#rid53">
          53
         </a>
         ]. Males in the highest compared with lowest tertile of cadmium intake had an increased risk of developing a fracture (hazard ratio [HR] 1.19, 95% CI 1.06-1.34) after controlling for potential confounders.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Using multivariable-adjusted linear regression, dietary cadmium exposure and urinary cadmium were related to total-body bone mineral density and risk of osteoporosis and fractures in 2676 females aged 56 to 69 years. High dietary cadmium exposure (≥13 mcg/day, median) compared with lower exposures (&lt;13 mcg/day) was associated with a 32 percent increased risk of osteoporosis (95% CI 2-71 percent) and 31 percent increased risk for any first incident fracture (95% CI 2-69 percent) [
         <a href="#rid55">
          55
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In an analysis of data from 10,978 subjects (aged 30 to 90 years) from the Third National Health and Nutrition Examination Survey (NHANES), the multivariable adjusted risk of osteopenia and osteoporosis increased at each level of urinary cadmium in both males and females [
         <a href="#rid54">
          54
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Not all studies have found such an association, however. As an example, a Japanese cross-sectional study of more than 1300 individuals with long-term cadmium exposure from food reported no significant association of cadmium with bone density [
         <a href="#rid56">
          56
         </a>
         ]. However, the assessment of dietary cadmium intake in this study was potentially biased since it did not correlate with urinary cadmium excretion.
        </p>
        <p class="headingAnchor" id="H53299950">
         <span class="h4">
          Potential mechanisms
         </span>
         <span class="headingEndMark">
          —
         </span>
         The mechanism underlying cadmium-associated bone disease is not well understood. One hypothesis suggests that the accumulation of cadmium in kidney tubular cells causes a reduction in the activation of calcidiol to calcitriol, resulting in decreased calcium absorption from the gut and impaired bone mineralization and eventually osteoporosis or osteomalacia [
         <a href="#rid57">
          57
         </a>
         ].
        </p>
        <p>
         Other mechanisms, however, may also be involved. A direct toxic effect from cadmium on the bone is suggested by several epidemiologic studies that documented associations between cadmium exposure and lower bone mineral density in the absence of any evidence for renal tubular injury [
         <a href="#rid2">
          2,3
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h3">
          Lung toxicity and cancer
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is experimental and epidemiologic evidence linking exposure to cadmium to respiratory cancer [
         <a href="#rid58">
          58
         </a>
         ]. In 1993, the International Agency for Research on Cancer (IARC) concluded that inhaled cadmium should be considered a human carcinogen [
         <a href="#rid59">
          59
         </a>
         ]; this interpretation, however, has been challenged [
         <a href="#rid60">
          60,61
         </a>
         ]. Nevertheless, a summary evaluation of existing studies found that both lung cancer and kidney dysfunction should be considered "critical effects" from exposure to cadmium [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         The relationship between cadmium and lung cancer was explored in an epidemiologic study from Belgium. Lung cancer incidence among 521 individuals residing in a cadmium-contaminated zinc smelter area was compared with that in 473 individuals with low environmental exposure [
         <a href="#rid62">
          62
         </a>
         ]. During a median follow-up of 17 years, 3 and 16 lung cancers occurred in the low- and high-exposure areas, respectively, for an incidence of 0.4 versus 1.8 per 1000 patient-years at risk, respectively. In multivariate analyses adjusted for smoking, age, and sex, the hazard ratio was 4.2 (95% CI 1.2-14) for high- versus low-exposure areas, respectively, and 1.7 (95% CI 1.1-2.6) for doubling of 24-hour urinary cadmium excretion. However, concomitant exposure to arsenic, a well-known human carcinogen, occurred in the exposed area. This was adjusted for in the epidemiologic analyses, but the possibility for residual confounding from arsenic, or some other contaminant in the zinc smelter area, cannot be ruled out completely [
         <a href="#rid63">
          63
         </a>
         ].
        </p>
        <p>
         Continued inhalational exposure to cadmium can give rise to obstructive lung disease and emphysema [
         <a href="#rid1">
          1,8
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H614936488">
         <span class="h2">
          Clinical presentation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most patients with chronic cadmium toxicity are asymptomatic for kidney disease, although they may have symptoms and/or a previously established diagnosis of osteoporosis. (See
         <a class="medical medical_review" href="/z/d/html/2052.html" rel="external">
          "Clinical manifestations, diagnosis, and evaluation of osteoporosis in men", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
         Patients with cadmium-associated kidney disease may have mild laboratory abnormalities that are detected as part of evaluation of unrelated presentation. Such laboratory abnormalities include mildly increased protein excretion (reflecting decreased tubular reabsorption of beta2-microglobulin, retinol binding protein, and human complex-forming glycoprotein HC [protein HC]), as well as a mild metabolic acidosis and glucosuria, amino aciduria, or phosphaturia, consistent with a proximal tubular defect with Fanconi syndrome. (See
         <a class="medical medical_review" href="/z/d/html/2328.html" rel="external">
          "Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis", section on 'Proximal (type 2) RTA'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2328.html" rel="external">
          "Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
         Although patients with cadmium-associated kidney disease may have increased excretion of low-molecular-weight proteins (such as beta2-microglobulin), this is not detected by urine dipstick, which detects only albumin [
         <a href="#rid11">
          11
         </a>
         ]. However, mild increases in protein excretion (ie, &lt;500 mg/day) may be detected by protein quantitation of a 24-hour urine collection or by protein-to-creatinine ratio in a spot urine. As noted above, occasional patients with cadmium toxicity may have increased albumin excretion, which is detectable by urine dipstick; however, this is uncommon.
        </p>
        <p>
         Some patients present with symptoms of a concentrating defect with complaints of nocturia or polyuria. (See
         <a class="medical medical_review" href="/z/d/html/2381.html" rel="external">
          "Evaluation of patients with polyuria", section on 'Arginine vasopressin resistance (AVP-R)'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6877.html" rel="external">
          "Nocturia: Clinical presentation, evaluation, and management in adults", section on 'Polyuria'
         </a>
         .)
        </p>
        <p>
         Some patients come to attention because of recurrent calcium-containing stones, and the evaluation reveals hypercalciuria. (See
         <a class="medical medical_review" href="/z/d/html/2369.html" rel="external">
          "Nephrolithiasis in renal tubular acidosis", section on 'Proximal (type 2) RTA'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7375.html" rel="external">
          "Kidney stones in adults: Epidemiology and risk factors", section on 'High urine calcium'
         </a>
         .)
        </p>
        <p>
         A small number of patients may present with reduced eGFR that is detected as a part of evaluation for an unrelated presentation or, rarely, with symptoms and laboratory manifestations of ESKD. (See
         <a class="medical medical_review" href="/z/d/html/7172.html" rel="external">
          "Overview of the management of chronic kidney disease in adults", section on 'Treatment of the complications of severe CKD'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9037519">
         <span class="h2">
          Diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of chronic cadmium toxicity should be considered in patients with a history of exposure who present with signs of interstitial kidney disease or signs or symptoms of osteoporosis.
        </p>
        <p>
         The diagnosis of chronic cadmium toxicity is made by determination of increased cadmium in urine and by the demonstration of increased excretion of tubular proteins in the appropriate clinical setting. Cadmium in urine reflects the cumulative cadmium exposure. The urine cadmium should be adjusted for dilution by calculating the cadmium/creatinine ratio [
         <a href="#rid7">
          7,64
         </a>
         ]. There is no absolute cadmium/creatinine ratio that is considered diagnostic, but, in clear cases of cadmium nephrotoxicity, it is usually &gt;5 nmol Cd/mmol creatinine. In the setting of a history of exposure to cadmium or clinical evidence of toxicity (such as a Fanconi syndrome and increased urinary excretion of beta2-microglobulin), abnormally increased blood cadmium concentration and urinary cadmium/creatinine ratio should be considered evidence of chronic toxicity [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p>
         Increased excretion of at least one tubular protein should be demonstrated to confirm the diagnosis of cadmium nephrotoxicity. Several highly sensitive indicators of tubular damage have been developed and used in cross-sectional and epidemiologic studies in cadmium-exposed groups. We first measure the urinary excretion of beta2-microglobulin. Among patients who have increased blood and urinary cadmium concentrations, an increase in beta2-microglobulin excretion &gt;0.3 mg/g creatinine is considered diagnostic. Beta2-microglobulin is a low-molecular plasma protein with a molecular weight of 12,000 and is easily detected using radioimmunoassays. Beta2-microglobulin is freely filtered by the glomerulus and almost completely (&gt;99.9 percent) reabsorbed in the proximal tubule. Even small changes in tubular reabsorptive capacity result in a marked increase in urinary beta2-microglobulin excretion [
         <a href="#rid1">
          1
         </a>
         ]. The United States OSHA requires that an employer take action if a cadmium-exposed worker demonstrates a urinary beta microglobulin concentration exceeding 750 mcg/g creatinine, though nonmandatory levels for removal from work exposure are advised for concentrations between 300 and 750 mcg/g creatinine. A table outlining OSHA recommendations in response to elevated surveillance levels for blood or urine cadmium, or beta2-microglobulin excretion, is available  (
         <a class="graphic graphic_table graphicRef107690" href="/z/d/graphic/107690.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
         However, measurement of beta2-microglobulin is less sensitive for diagnosis among patients who have acidic urine since the protein degrades in an acid pH. Thus, among patients who have acidic urine (pH &lt;5.6) and do not have or have only a mild increase in urinary beta2-microglobulin, we measure either retinol binding protein, human complex-forming glycoprotein (protein HC or alpha-1-microglobulin), or apolipoprotein. These are equally sensitive but less widely used indicators of cadmium-induced tubular damage.
        </p>
        <p>
         These plasma proteins are all filtered through the glomerulus. Other urinary markers indicative of a subtle tubulotoxic effect are increased excretion of N-acetyl-beta-D-glucosaminidase (NAG), an enzyme localized in lysosomes of the tubular cells, and kidney injury molecule-1 (KIM-1), a transmembrane protein expressed in proximal tubule cells after injury [
         <a href="#rid36">
          36,66
         </a>
         ]. However, these are generally not used clinically.
        </p>
        <p class="headingAnchor" id="H9035483">
         <span class="h2">
          Prevention of chronic toxicity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Minimizing exposure to cadmium is the most important therapeutic measure. To reduce the risk of cadmium toxicity, as for many other reasons, we recommend stopping smoking (see
         <a class="medical medical_review" href="/z/d/html/1504.html" rel="external">
          "Cardiovascular risk of smoking and benefits of smoking cessation", section on 'Summary and recommendations'
         </a>
         ). In addition, occupational exposure should be kept as low as technically feasible, preferably below 0.005 mg/m
         <sup>
          3
         </sup>
         . Exposure via food should be kept well below 30 mcg Cd/day [
         <a href="#rid67">
          67
         </a>
         ].
        </p>
        <p>
         There is very little margin of safety between levels of cadmium found in human kidneys and the levels in which early kidney dysfunction can occur in susceptible individuals. Subtle kidney and bone effects likely still occur in certain areas where cadmium pollution is severe. As a result, actions aimed at decreasing pollution from and human exposure to cadmium are well founded.
        </p>
        <p class="headingAnchor" id="H9035139">
         <span class="h2">
          Treatment of chronic toxicity
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is no specific therapy for cadmium-associated chronic kidney disease (CKD) [
         <a href="#rid11">
          11
         </a>
         ]. Cadmium-induced osteomalacia has been treated with large doses of vitamin D [
         <a href="#rid11">
          11
         </a>
         ]. Sources of cadmium exposure should be avoided as much as possible.
        </p>
        <p class="headingAnchor" id="H9035304">
         <span class="h2">
          Prognosis of chronic toxicity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Increased mortality among Japanese farmers with proteinuria due to chronic environmental exposure to cadmium has been observed in several epidemiologic studies [
         <a href="#rid7">
          7,68-76
         </a>
         ]. A 15-year follow-up of 3178 inhabitants in a cadmium-polluted area of Japan revealed a dose-related increase in the overall age-adjusted mortality with increasing urinary excretion of beta2-microglobulin [
         <a href="#rid72">
          72
         </a>
         ]. People with an initial examination showing urine beta2-microglobulin exceeding 1 to 10 mg/g creatinine had more than twice the mortality compared with those with normal values (&lt;0.3 mg/g creatinine) [
         <a href="#rid72">
          72,73
         </a>
         ]. The elevated mortality rate is associated with cardiovascular and kidney diseases [
         <a href="#rid73">
          73,74
         </a>
         ]. Another study followed 3281 inhabitants (1544 males and 1737 females) of a separate cadmium-contaminated region from Japan; kidney disease and kidney disease-associated mortality were increased, and among females, all-cause mortality was elevated [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p>
         Taken together, available epidemiologic evidence indicates that the initial, rather subtle kidney effects from cadmium in the form of a tubular proteinuria eventually may develop, or at least contribute, to more severe kidney disease and increased mortality [
         <a href="#rid27">
          27,73
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H537395173">
         <span class="h1">
          ACUTE CADMIUM TOXICITY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acute cadmium toxicity is rare but occurs in the setting of both inhalational [
         <a href="#rid77">
          77,78
         </a>
         ] and oral [
         <a href="#rid79">
          79,80
         </a>
         ] exposure.
        </p>
        <p class="headingAnchor" id="H537395185">
         <span class="h2">
          Acute inhalational (pulmonary) exposure
         </span>
         <span class="headingEndMark">
          —
         </span>
         Inhalational exposure to cadmium may cause severe pneumonitis, which can progress to acute respiratory distress syndrome (ARDS) and pulmonary hemorrhage. Acute pulmonary exposure to cadmium oxide occurs when welders use cadmium-containing solders or braze cadmium-containing objects without appropriate pulmonary precautions [
         <a href="#rid77">
          77,81-85
         </a>
         ]. In these scenarios, the liberation of cadmium oxide at first produces only mild irritant symptoms (if any), which may facilitate ongoing exposure [
         <a href="#rid86">
          86,87
         </a>
         ]. The initial symptoms of cadmium pneumonitis usually occur hours after the initial exposure, and include sore throat, cough and dyspnea [
         <a href="#rid87">
          87
         </a>
         ]. Early cadmium pneumonitis resembles metal fume fever, a more common condition caused by the inhalation of oxides of other metals such as zinc or magnesium. However, metal fume fever is almost always benign and self-limited, whereas cadmium pneumonitis may progress to severe dyspnea, hypoxia, and respiratory failure. The initial chest radiograph in cadmium pneumonitis may be normal but in severe cases will progress to an ARDS pattern (see
         <a class="medical medical_review" href="/z/d/html/1637.html" rel="external">
          "Acute respiratory distress syndrome: Clinical features, diagnosis, and complications in adults"
         </a>
         ). In such patients, cadmium pneumonitis is often fatal [
         <a href="#rid77">
          77,78,88
         </a>
         ]. Although chronic pulmonary sequelae after cadmium pneumonitis are reported [
         <a href="#rid82">
          82,83,85
         </a>
         ], the extent to which cadmium is the causative agent is unclear.
        </p>
        <p>
         Inhalational cadmium toxicity also can cause renal and hepatic injury [
         <a href="#rid86">
          86,87
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H537395646">
         <span class="h2">
          Acute oral exposure
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acute exposure to oral cadmium is very rare but significant; ingestion of cadmium salts results in substantial local tissue injury. In two documented cases of single-dose cadmium poisoning, oropharyngeal edema and gastrointestinal bleeding were prominent clinical findings [
         <a href="#rid79">
          79,80
         </a>
         ]. A third case of suspected oral exposure, which may have occurred over months, presented with an anemia that was initially suspected to be autoimmune hemolytic in nature [
         <a href="#rid89">
          89
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Prevention of acute toxicity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Avoiding exposure to cadmium is the most important preventive measure. Occupational exposure should be kept as low as technically feasible. Inhalational exposure may be avoided by wearing appropriate protective equipment.
        </p>
        <p class="headingAnchor" id="H432882713">
         <span class="h2">
          Diagnosis of acute toxicity
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of acute cadmium toxicity rests entirely on the clinical presentation and a history of exposure to cadmium. The diagnosis is usually confirmed by analysis of cadmium in blood, which reflects recent cadmium exposure. We also check urine cadmium to determine whether there is concomitant chronic exposure to cadmium. Cadmium in urine (adjusted for dilution by calculating the cadmium/creatinine ratio) indicates accumulation or kidney burden of cadmium [
         <a href="#rid7">
          7,64
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Treatment of acute toxicity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other than general supportive therapy, there are no specific methods available for treating acute cadmium ingestion or inhalation. Although various chelating agents have been tried in animals, none have been shown to be efficient in humans. In the event of an acute cadmium exposure (inhalation or oral), the provider should contact a poison control center immediately. (See
         <a class="local">
          'Additional resources'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1955673492">
         <span class="h2">
          Additional resources
         </span>
         <span class="headingEndMark">
          —
         </span>
         Regional poison control centers in the United States are available for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have clinical and/or medical toxicologists available for bedside consultation and/or inpatient care. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. Contact information for regional poison centers around the world is available
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.liquidglassnanotech.com%2Fpoison-emergency-center-contact-numbers%2F&amp;token=WPLlYiGN4sfAHHOr06dbfW58cJxiRkVNH0Y7Xfw1x51Ys7RnJutw48LAQ4uquyIKfaCYvWA0XnuOv234wrMsT2DQ2OILEuZCQdU1mpiDN80%3D&amp;TOPIC_ID=7202" target="_blank">
          here
         </a>
         .
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          Prognosis of acute toxicity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Based on limited data from case reports, the morbidity and mortality associated with acute cadmium toxicity are very high.
        </p>
        <p class="headingAnchor" id="H8245779">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/83756.html" rel="external">
          "Patient education: Cadmium toxicity (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H20840495">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Overview
         </strong>
         – Cadmium (Cd) may cause severe chronic or acute toxicity. Prolonged cadmium exposure principally affects the kidneys and bones. Acute toxicity is mainly via inhalation. (See
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="local">
          'Disease associations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sources of exposure
         </strong>
         – Exposure to cadmium principally results from eating contaminated food, smoking cigarettes, and working in cadmium-contaminated workplaces. (See
         <a class="local">
          'Source of exposure'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Chronic toxicity
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Clinical manifestations
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Kidney disease
         </strong>
         – The earliest sign of cadmium nephrotoxicity is tubular proteinuria. Other manifestations include glucosuria, aminoaciduria, phosphate wasting, hypercalciuria, polyuria due to decreased concentration capacity, decreased glomerular filtration rate (GFR), and a mild metabolic acidosis. Some patients may present with kidney stones from hypercalciuria. Patients may present with or progress to end-stage kidney disease (ESKD), but this is uncommon. In addition to cadmium exposure, risk factors for nephrotoxicity include age, diabetes mellitus, and iron deficiency. (See
         <a class="local">
          'Kidney disease'
         </a>
         above and
         <a class="local">
          'Risk factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Bone disease
         </strong>
         – Cadmium toxicity is associated with osteoporosis and fractures, which appears to be dose related. The mechanism by which cadmium causes bone disease is not completely clear. (See
         <a class="local">
          'Bone disease'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Lung disease
         </strong>
         – Cadmium exposure may cause significant toxicity of the lungs, including lung cancer. (See
         <a class="local">
          'Lung toxicity and cancer'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of chronic cadmium toxicity should be considered in patients with a history of exposure who present with signs and/or symptoms of interstitial kidney disease or osteoporosis. The diagnosis of chronic cadmium toxicity is made by analysis of cadmium in urine in the appropriate clinical setting. The increased excretion of at least one tubular protein should be demonstrated to confirm the diagnosis of cadmium nephrotoxicity. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute toxicity
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Clinical manifestations
         </strong>
         – Acute cadmium toxicity is rare but may occur after inhalational exposure and give rise to influenza-like symptoms including fever and pains in muscles and joints shortly (less than 12 hours) after exposure. A severe and fatal chemical pneumonitis may develop. Acute oral exposure is very rare but may cause oropharyngeal edema and gastrointestinal bleeding. (See
         <a class="local">
          'Acute cadmium toxicity'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Diagnosis, treatment, and prognosis
         </strong>
         – The diagnosis of acute cadmium toxicity rests entirely on the clinical presentation and a history of exposure to cadmium. The diagnosis is usually confirmed by analysis of cadmium in blood. Other than general supportive therapy, there are no specific methods available for treating acute cadmium ingestion or inhalation. The morbidity and mortality associated with acute toxicity are very high. (See
         <a class="local">
          'Acute cadmium toxicity'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1063831416">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Stephen Traub, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          WHO. Cadmium. Environmental Health Criteria. WHO, Geneva, 1992. p.280.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schutte R, Nawrot TS, Richart T, et al. Bone resorption and environmental exposure to cadmium in women: a population study. Environ Health Perspect 2008; 116:777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nawrot T, Geusens P, Nulens TS, Nemery B. Occupational cadmium exposure and calcium excretion, bone density, and osteoporosis in men. J Bone Miner Res 2010; 25:1441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nriagu JO, Pacyna JM. Quantitative assessment of worldwide contamination of air, water and soils by trace metals. Nature 1988; 333:134.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elinder CG, Järup L. Cadmium exposure and health risks: Recent findings. Ambio 1996; 25:370.
          </a>
         </li>
         <li class="breakAll">
          Elinder CG. Uses, occurrence and intake. In: Cadmium and Health: An Epidemiologic and Toxicological Appraisal, Friberg L, Elinder CG, Nordberg GF, et al (Eds), CRC Press, Boca Raton, FL 1985. Vol 1, p.23.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Järup L, Berglund M, Elinder CG, et al. Health effects of cadmium exposure--a review of the literature and a risk estimate. Scand J Work Environ Health 1998; 24 Suppl 1:1.
          </a>
         </li>
         <li class="breakAll">
          Friberg L, Elinder CG, Kjellström T, et al. Cadmium and health: A toxiciological and epidemiologic appraisal, CRC Press, Boca Raton, FL 1985. Vol 1 - Exposure, dose, and metabolism, p.209.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nogawa K, Kobayashi E, Okubo Y, Suwazono Y. Environmental cadmium exposure, adverse effects and preventive measures in Japan. Biometals 2004; 17:581.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bernhoft RA. Cadmium toxicity and treatment. ScientificWorldJournal 2013; 2013:394652.
          </a>
         </li>
         <li class="breakAll">
          Friberg L, Elinder CG, Kjellström T, et al. Cadmium and Health: A toxicological and epidemiologic appraisal, CRC Press, Boca Raton, FL 1986. Vol Vol II: Effects and Response, p.307.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vanderpool RA, Reeves PG. Cadmium absorption in women fed processed edible sunflower kernels labeled with a stable isotope of cadmium, (113)Cd. Environ Res 2001; 87:69.
          </a>
         </li>
         <li class="breakAll">
          ATSDR. Toxicological Profile for Cadmium. US Department of Health and Human Services, 2008.
         </li>
         <li>
          <a class="nounderline abstract_t">
           FRIBERG L. Health hazards in the manufacture of alkaline accumulators with special reference to chronic cadmium poisoning; a clinical and experimental study. Acta Med Scand Suppl 1950; 240:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           BUTLER EA, FLYNN FV. The proteinuria of renal tubular disorders. Lancet 1958; 2:978.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roels H, Djubgang J, Buchet JP, et al. Evolution of cadmium-induced renal dysfunction in workers removed from exposure. Scand J Work Environ Health 1982; 8:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elinder CG, Edling C, Lindberg E, et al. beta 2-Microglobulinuria among workers previously exposed to cadmium: follow-up and dose-response analyses. Am J Ind Med 1985; 8:553.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mason HJ, Williams N, Armitage S, et al. Follow up of workers previously exposed to silver solder containing cadmium. Occup Environ Med 1999; 56:553.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Satarug S, Vesey DA, Gobe GC, Phelps KR. The pathogenesis of albuminuria in cadmium nephropathy. Curr Res Toxicol 2024; 6:100140.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Vleet TR, Schnellmann RG. Toxic nephropathy: environmental chemicals. Semin Nephrol 2003; 23:500.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xia X, Wang G, Peng Y, et al. The endogenous CXXC motif governs the cadmium sensitivity of the renal Na+/glucose co-transporter. J Am Soc Nephrol 2005; 16:1257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hotz P, Buchet JP, Bernard A, et al. Renal effects of low-level environmental cadmium exposure: 5-year follow-up of a subcohort from the Cadmibel study. Lancet 1999; 354:1508.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Järup L, Elinder CG. Incidence of renal stones among cadmium exposed battery workers. Br J Ind Med 1993; 50:598.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scott R, Patterson PJ, Burns R, et al. Hypercalciuria related to cadmium exposure. Urology 1978; 11:462.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu X, Jin T, Wang Z, et al. Urinary calcium as a biomarker of renal dysfunction in a general population exposed to cadmium. J Occup Environ Med 2001; 43:898.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Järup L, Persson B, Elinder CG. Decreased glomerular filtration rate in solderers exposed to cadmium. Occup Environ Med 1995; 52:818.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hellström L, Elinder CG, Dahlberg B, et al. Cadmium exposure and end-stage renal disease. Am J Kidney Dis 2001; 38:1001.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nogawa K. Biologic indicators of cadmium nephrotoxicity in persons with low-level cadmium exposure. Environ Health Perspect 1984; 54:163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           BONNELL JA, ROSS JH, KING E. Renal lesions in experimental cadmium poisoning. Br J Ind Med 1960; 17:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barregard L, Sallsten G, Lundh T, Mölne J. Low-level exposure to lead, cadmium and mercury, and histopathological findings in kidney biopsies. Environ Res 2022; 211:113119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elinder CG, Jönsson L, Piscator M, Rahnster B. Histopathological changes in relation to cadmium concentration in horse kidneys. Environ Res 1981; 26:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buchet JP, Lauwerys R, Roels H, et al. Renal effects of cadmium body burden of the general population. Lancet 1990; 336:699.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cai SW, Yue L, Hu ZN, et al. Cadmium exposure and health effects among residents in an irrigation area with ore dressing wastewater. Sci Total Environ 1990; 90:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Järup L, Elinder CG. Dose-response relations between urinary cadmium and tubular proteinuria in cadmium-exposed workers. Am J Ind Med 1994; 26:759.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bernard A, Buchet JP, Roels H, et al. Renal excretion of proteins and enzymes in workers exposed to cadmium. Eur J Clin Invest 1979; 9:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mueller PW, Smith SJ, Steinberg KK, Thun MJ. Chronic renal tubular effects in relation to urine cadmium levels. Nephron 1989; 52:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Järup L, Hellström L, Alfvén T, et al. Low level exposure to cadmium and early kidney damage: the OSCAR study. Occup Environ Med 2000; 57:668.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akesson A, Lundh T, Vahter M, et al. Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ Health Perspect 2005; 113:1627.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akerstrom M, Sallsten G, Lundh T, Barregard L. Associations between urinary excretion of cadmium and proteins in a nonsmoking population: renal toxicity or normal physiology? Environ Health Perspect 2013; 121:187.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haddam N, Samira S, Dumont X, et al. Confounders in the assessment of the renal effects associated with low-level urinary cadmium: an analysis in industrial workers. Environ Health 2011; 10:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chaumont A, De Winter F, Dumont X, et al. The threshold level of urinary cadmium associated with increased urinary excretion of retinol-binding protein and beta 2-microglobulin: a re-assessment in a large cohort of nickel-cadmium battery workers. Occup Environ Med 2011; 68:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oosterwijk MM, Hagedoorn IJM, Maatman RGHJ, et al. Cadmium, active smoking and renal function deterioration in patients with type 2 diabetes. Nephrol Dial Transplant 2023; 38:876.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kido T, Nogawa K, Yamada Y, et al. Osteopenia in inhabitants with renal dysfunction induced by exposure to environmental cadmium. Int Arch Occup Environ Health 1989; 61:271.
          </a>
         </li>
         <li class="breakAll">
          Nordberg GF, Nogawa K, Nordberg M, Friberg LT. Cadmium. In: Handbook on the Toxicology of Metals, Nordberg GF, Fowler BA, Nordberg M (Eds), Academic Press/Elsevier, Amsterdam 2014. Vol 2, p.667.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paul J, Cherian KE, Thomas N, Paul TV. Hypophosphataemic osteomalacia due to cadmium exposure in the silver industry. Occup Med (Lond) 2020; 70:207.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Järup L, Alfvén T, Persson B, et al. Cadmium may be a risk factor for osteoporosis. Occup Environ Med 1998; 55:435.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Staessen JA, Roels HA, Emelianov D, et al. Environmental exposure to cadmium, forearm bone density, and risk of fractures: prospective population study. Public Health and Environmental Exposure to Cadmium (PheeCad) Study Group. Lancet 1999; 353:1140.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alfvén T, Elinder CG, Carlsson MD, et al. Low-level cadmium exposure and osteoporosis. J Bone Miner Res 2000; 15:1579.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alfvén T, Järup L, Elinder CG. Cadmium and lead in blood in relation to low bone mineral density and tubular proteinuria. Environ Health Perspect 2002; 110:699.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akesson A, Bjellerup P, Lundh T, et al. Cadmium-induced effects on bone in a population-based study of women. Environ Health Perspect 2006; 114:830.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alfvén T, Elinder CG, Hellström L, et al. Cadmium exposure and distal forearm fractures. J Bone Miner Res 2004; 19:900.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Engström A, Michaëlsson K, Suwazono Y, et al. Long-term cadmium exposure and the association with bone mineral density and fractures in a population-based study among women. J Bone Miner Res 2011; 26:486.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomas LD, Michaëlsson K, Julin B, et al. Dietary cadmium exposure and fracture incidence among men: a population-based prospective cohort study. J Bone Miner Res 2011; 26:1601.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu Q, Magnus JH, Hentz JG. Urinary cadmium, osteopenia, and osteoporosis in the US population. Osteoporos Int 2010; 21:1449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Engström A, Michaëlsson K, Vahter M, et al. Associations between dietary cadmium exposure and bone mineral density and risk of osteoporosis and fractures among women. Bone 2012; 50:1372.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horiguchi H, Oguma E, Sasaki S, et al. Environmental exposure to cadmium at a level insufficient to induce renal tubular dysfunction does not affect bone density among female Japanese farmers. Environ Res 2005; 97:83.
          </a>
         </li>
         <li class="breakAll">
          Kjellström T. Mechanism and epidemiology of bone effects of cadium. In: Toxicity and Carcinogenicity of Cadmium in the Human Environment - An International Symposium, Nordberg GF, Herber RFM, Alessio L (Eds), 1992. p.301.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Takenaka S, Oldiges H, König H, et al. Carcinogenicity of cadmium chloride aerosols in W rats. J Natl Cancer Inst 1983; 70:367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cadmium and cadmium compounds. IARC Monogr Eval Carcinog Risks Hum 1993; 58:119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doll R. Is cadmium a human carcinogen? Ann Epidemiol 1992; 2:335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Järup L, Bellander T, Hogstedt C, Spång G. Mortality and cancer incidence in Swedish battery workers exposed to cadmium and nickel. Occup Environ Med 1998; 55:755.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nawrot T, Plusquin M, Hogervorst J, et al. Environmental exposure to cadmium and risk of cancer: a prospective population-based study. Lancet Oncol 2006; 7:119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nordberg GF. Lung cancer and exposure to environmental cadmium. Lancet Oncol 2006; 7:99.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wittman R, Hu H. Cadmium exposure and nephropathy in a 28-year-old female metals worker. Environ Health Perspect 2002; 110:1261.
          </a>
         </li>
         <li class="breakAll">
          Barregard L, Elinder CG. Renal effects from exposure to metals. In: Handbook on the Toxicology of Metals, Nordberg GF, Fowler BA, Nordberg M (Eds), Academic Press, Amsterdam 2014. Vol 1, p.333.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prozialeck WC, Vaidya VS, Liu J, et al. Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity. Kidney Int 2007; 72:985.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Satarug S, Haswell-Elkins MR, Moore MR. Safe levels of cadmium intake to prevent renal toxicity in human subjects. Br J Nutr 2000; 84:791.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nishijo M, Nakagawa H, Morikawa Y, et al. Prognostic factors of renal dysfunction induced by environmental cadmium pollution. Environ Res 1994; 64:112.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iwata K, Saito H, Moriyama M, Nakano A. Follow up study of renal tubular dysfunction and mortality in residents of an area polluted with cadmium. Br J Ind Med 1992; 49:736.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nishijo M, Nakagawa H, Morikawa M, et al. Relationship between urinary cadmium and mortality among inhabitants living in a cadmium polluted area in Japan. Toxicol Lett 1999; 108:321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nishijo M, Nakagawa H, Suwazono Y, et al. Causes of death in patients with Itai-itai disease suffering from severe chronic cadmium poisoning: a nested case-control analysis of a follow-up study in Japan. BMJ Open 2017; 7:e015694.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nishijo M, Nakagawa H, Morikawa Y, et al. Mortality in a cadmium polluted area in Japan. Biometals 2004; 17:535.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nishijo M, Morikawa Y, Nakagawa H, et al. Causes of death and renal tubular dysfunction in residents exposed to cadmium in the environment. Occup Environ Med 2006; 63:545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nishijo M, Nakagawa H, Morikawa Y, et al. Mortality of inhabitants in an area polluted by cadmium: 15 year follow up. Occup Environ Med 1995; 52:181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nogawa K, Suwazono Y, Nishijo M, et al. Relationship between mortality and rice cadmium concentration in inhabitants of the polluted Jinzu River basin, Toyama, Japan: A 26 year follow-up. J Appl Toxicol 2018; 38:855.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nogawa K, Suwazono Y, Nishijo M, et al. Increase of lifetime cadmium intake dose-dependently increased all cause of mortality in female inhabitants of the cadmium-polluted Jinzu River basin, Toyama, Japan. Environ Res 2018; 164:379.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fuortes L, Leo A, Ellerbeck PG, Friell LA. Acute respiratory fatality associated with exposure to sheet metal and cadmium fumes. J Toxicol Clin Toxicol 1991; 29:279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seidal K, Jörgensen N, Elinder CG, et al. Fatal cadmium-induced pneumonitis. Scand J Work Environ Health 1993; 19:429.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buckler HM, Smith WD, Rees WD. Self poisoning with oral cadmium chloride. Br Med J (Clin Res Ed) 1986; 292:1559.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wiśniewska-Knypl J, Jablońska J, Myślak Z. Binding of cadmium on metallothionein in man: an analysis of a fatal poisoning by cadmium iodide. Arch Toxikol 1971; 28:46.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parikh JM, Dhareshwar S, Sharma A, et al. Acute respiratory distress in a silversmith. Indian J Occup Environ Med 2014; 18:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barnhart S, Rosenstock L. Cadmium chemical pneumonitis. Chest 1984; 86:789.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anthony JS, Zamel N, Aberman A. Abnormalities in pulmonary function after brief exposure to toxic metal fumes. Can Med Assoc J 1978; 119:586.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patwardhan JR, Finckh ES. Fatal cadmium-fume pneumonitis. Med J Aust 1976; 1:962.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Townshend RH. Acute cadmium pneumonitis: a 17-year follow-up. Br J Ind Med 1982; 39:411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beton DC, Andrews GS, Davies HJ, et al. Acute cadmium fume poisoning. Five cases with one death from renal necrosis. Br J Ind Med 1966; 23:292.
          </a>
         </li>
         <li class="breakAll">
          Clinical Assessment – Exposure History and Physical Examination. Agency for Toxic Substances and Disease Registry. Centers for Disease Control and Prevention. Available at: https://www.atsdr.cdc.gov/csem/cadmium/Clinical-Assessment.html (Accessed on January 02, 2024).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andujar P, Bensefa-Colas L, Descatha A. [Acute and chronic cadmium poisoning]. Rev Med Interne 2010; 31:107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raval G, Straughen JE, McMillin GA, Bornhorst JA. Unexplained hemolytic anemia with multiorgan failure. Clin Chem 2011; 57:1485.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 7202 Version 34.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : WHO. Cadmium. Environmental Health Criteria. WHO, Geneva, 1992. p.280.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18560534" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Bone resorption and environmental exposure to cadmium in women: a population study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20200937" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Occupational cadmium exposure and calcium excretion, bone density, and osteoporosis in men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3285219" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Quantitative assessment of worldwide contamination of air, water and soils by trace metals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Cadmium exposure and health risks: Recent findings
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Cadmium exposure and health risks: Recent findings
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9569444" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Health effects of cadmium exposure--a review of the literature and a risk estimate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9569444" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Health effects of cadmium exposure--a review of the literature and a risk estimate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15688869" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Environmental cadmium exposure, adverse effects and preventive measures in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23844395" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Cadmium toxicity and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23844395" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Cadmium toxicity and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11683590" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Cadmium absorption in women fed processed edible sunflower kernels labeled with a stable isotope of cadmium, (113)Cd.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11683590" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Cadmium absorption in women fed processed edible sunflower kernels labeled with a stable isotope of cadmium, (113)Cd.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15432153" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Health hazards in the manufacture of alkaline accumulators with special reference to chronic cadmium poisoning; a clinical and experimental study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13599454" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : The proteinuria of renal tubular disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7156938" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Evolution of cadmium-induced renal dysfunction in workers removed from exposure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3907336" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : beta 2-Microglobulinuria among workers previously exposed to cadmium: follow-up and dose-response analyses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10492654" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Follow up of workers previously exposed to silver solder containing cadmium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/38116328" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : The pathogenesis of albuminuria in cadmium nephropathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13680539" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Toxic nephropathy: environmental chemicals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15829715" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : The endogenous CXXC motif governs the cadmium sensitivity of the renal Na+/glucose co-transporter.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10551497" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Renal effects of low-level environmental cadmium exposure: 5-year follow-up of a subcohort from the Cadmibel study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8343420" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Incidence of renal stones among cadmium exposed battery workers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/209595" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Hypercalciuria related to cadmium exposure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11665459" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Urinary calcium as a biomarker of renal dysfunction in a general population exposed to cadmium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8563845" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Decreased glomerular filtration rate in solderers exposed to cadmium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11684553" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Cadmium exposure and end-stage renal disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6376089" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Biologic indicators of cadmium nephrotoxicity in persons with low-level cadmium exposure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13802553" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Renal lesions in experimental cadmium poisoning.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35288159" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Low-level exposure to lead, cadmium and mercury, and histopathological findings in kidney biopsies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7297523" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Histopathological changes in relation to cadmium concentration in horse kidneys.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1975890" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Renal effects of cadmium body burden of the general population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2305245" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Cadmium exposure and health effects among residents in an irrigation area with ore dressing wastewater.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7892827" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Dose-response relations between urinary cadmium and tubular proteinuria in cadmium-exposed workers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/110596" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Renal excretion of proteins and enzymes in workers exposed to cadmium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2565539" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Chronic renal tubular effects in relation to urine cadmium levels.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10984338" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Low level exposure to cadmium and early kidney damage: the OSCAR study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16263522" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23128055" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Associations between urinary excretion of cadmium and proteins in a nonsmoking population: renal toxicity or normal physiology?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21569589" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Confounders in the assessment of the renal effects associated with low-level urinary cadmium: an analysis in industrial workers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20935291" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : The threshold level of urinary cadmium associated with increased urinary excretion of retinol-binding protein and beta 2-microglobulin: a re-assessment in a large cohort of nickel-cadmium battery workers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36124748" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Cadmium, active smoking and renal function deterioration in patients with type 2 diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2722250" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Osteopenia in inhabitants with renal dysfunction induced by exposure to environmental cadmium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2722250" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Osteopenia in inhabitants with renal dysfunction induced by exposure to environmental cadmium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31974582" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Hypophosphataemic osteomalacia due to cadmium exposure in the silver industry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9816375" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Cadmium may be a risk factor for osteoporosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10209978" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Environmental exposure to cadmium, forearm bone density, and risk of fractures: prospective population study. Public Health and Environmental Exposure to Cadmium (PheeCad) Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10934657" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Low-level cadmium exposure and osteoporosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12117647" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Cadmium and lead in blood in relation to low bone mineral density and tubular proteinuria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16759980" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Cadmium-induced effects on bone in a population-based study of women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15125789" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Cadmium exposure and distal forearm fractures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20734452" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Long-term cadmium exposure and the association with bone mineral density and fractures in a population-based study among women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21404330" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Dietary cadmium exposure and fracture incidence among men: a population-based prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19937228" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Urinary cadmium, osteopenia, and osteoporosis in the US population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22465267" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Associations between dietary cadmium exposure and bone mineral density and risk of osteoporosis and fractures among women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15476737" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Environmental exposure to cadmium at a level insufficient to induce renal tubular dysfunction does not affect bone density among female Japanese farmers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15476737" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Environmental exposure to cadmium at a level insufficient to induce renal tubular dysfunction does not affect bone density among female Japanese farmers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6571943" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Carcinogenicity of cadmium chloride aerosols in W rats.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8022055" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Cadmium and cadmium compounds.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1342284" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Is cadmium a human carcinogen?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9924452" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Mortality and cancer incidence in Swedish battery workers exposed to cadmium and nickel.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16455475" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Environmental exposure to cadmium and risk of cancer: a prospective population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16455471" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Lung cancer and exposure to environmental cadmium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12460807" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Cadmium exposure and nephropathy in a 28-year-old female metals worker.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12460807" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Cadmium exposure and nephropathy in a 28-year-old female metals worker.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17687258" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11177195" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Safe levels of cadmium intake to prevent renal toxicity in human subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8306946" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Prognostic factors of renal dysfunction induced by environmental cadmium pollution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1419864" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Follow up study of renal tubular dysfunction and mortality in residents of an area polluted with cadmium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10511278" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Relationship between urinary cadmium and mortality among inhabitants living in a cadmium polluted area in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28710217" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Causes of death in patients with Itai-itai disease suffering from severe chronic cadmium poisoning: a nested case-control analysis of a follow-up study in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15688859" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Mortality in a cadmium polluted area in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16601012" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Causes of death and renal tubular dysfunction in residents exposed to cadmium in the environment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7735391" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Mortality of inhabitants in an area polluted by cadmium: 15 year follow up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29377184" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Relationship between mortality and rice cadmium concentration in inhabitants of the polluted Jinzu River basin, Toyama, Japan: A 26 year follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29571127" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Increase of lifetime cadmium intake dose-dependently increased all cause of mortality in female inhabitants of the cadmium-polluted Jinzu River basin, Toyama, Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2051514" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Acute respiratory fatality associated with exposure to sheet metal and cadmium fumes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8153597" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Fatal cadmium-induced pneumonitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3087515" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Self poisoning with oral cadmium chloride.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5569102" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Binding of cadmium on metallothionein in man: an analysis of a fatal poisoning by cadmium iodide.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25006313" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Acute respiratory distress in a silversmith.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6488924" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Cadmium chemical pneumonitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/213181" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Abnormalities in pulmonary function after brief exposure to toxic metal fumes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/185501" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Fatal cadmium-fume pneumonitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7138802" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Acute cadmium pneumonitis: a 17-year follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5928153" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Acute cadmium fume poisoning. Five cases with one death from renal necrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5928153" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Acute cadmium fume poisoning. Five cases with one death from renal necrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19709784" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : [Acute and chronic cadmium poisoning].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22039156" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Unexplained hemolytic anemia with multiorgan failure.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
